e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Novel insights into the pathophysiology of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bone marrow progenitor cells in patients with COPD
A. Jahn, C. Balaguer, M. A. Duran, J. Iglesias, A. Rios, F. Polverino, A. Iglesias, C. Crespi, E. Sala, A. Agusti, B. G. Cosio (Palma de Mallorca, Barcelona, Spain)
Source:
Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Session:
Novel insights into the pathophysiology of asthma and COPD
Session type:
Thematic Poster Session
Number:
2467
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Jahn, C. Balaguer, M. A. Duran, J. Iglesias, A. Rios, F. Polverino, A. Iglesias, C. Crespi, E. Sala, A. Agusti, B. G. Cosio (Palma de Mallorca, Barcelona, Spain). Bone marrow progenitor cells in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 2467
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients
Source: ERJ Open Res 2016: 00045-2015
Year: 2016
The contribution of bone marrow derived progenitor cells to lung remodelling
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Bone marrow characteristics in patients with COPD and eosinophilia
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Phenotypical and molecular characteristics of bone marrow mesenchymal stem cells in rheumatoid lung
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Lung transplantation after bone marrow transplantationin paediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 725s
Year: 2006
Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair
in vitro
Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly?
Year: 2007
Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic
Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases
Year: 2014
Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Hypoxia and the bone marrow
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005
Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
HGF expressing stem cells in the human fibrotic lung originate from the bone marrow
Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Year: 2011
In vivo
chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2008 - Pathophysiology of acute lung injury
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept